Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Moelis & Company filings document financial results, governance matters and capital-structure disclosures for a NYSE-listed independent investment bank. Form 8-K reports include earnings releases, Regulation FD presentation updates, board appointments and related material-event disclosures tied to the firm’s advisory business.
Proxy materials cover annual meeting matters, director elections, board committee structure, independence determinations and director compensation. The filings also identify the company’s Class A common stock registered under Section 12(b) and traded on the New York Stock Exchange under the symbol MC.
Moelis & Co’s Class A common stock has a significant institutional holder in Wasatch Advisors, a Delaware entity that filed Amendment No. 1 to a Schedule 13G. Wasatch Advisors reports beneficial ownership of 3,246,593 Class A shares, representing 4.4% of that class.
Wasatch Advisors has sole voting power over 2,329,525 shares and sole dispositive power over all 3,246,593 shares, with no shared voting or dispositive power. The filing states that this position represents ownership of 5 percent or less of the outstanding Class A shares.
Barker Thorold reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Barker Thorold received an equity compensation grant of 1,545 2026 Annual Restricted Stock Units. Each RSU represents the right to receive one share of Class A common stock. The RSUs vested on July 1, 2026, with settlement to occur within 60 days following July 1, 2028.
The grant was made to a non-employee director based on a reference price of $64.68 per share, calculated as the average closing price of the Class A common stock on the NYSE over the five trading days ended June 30, 2026. Following this grant, Thorold holds 1,545 shares/units directly.
Mirrer Louise reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Louise Mirrer reported a new equity award. On July 1, 2026, she received 1,623 "2026 Annual Restricted Stock Units" as a grant of compensation. Each RSU represents the right to receive one share of Class A common stock.
The 2026 Annual Restricted Stock Units vested on July 1, 2026, with settlement to occur within 60 days following July 1, 2028. The award was valued using $64.68 per share, the average closing price of the company’s Class A common stock on the NYSE for the five trading days ended June 30, 2026.
Worrell Laila reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Laila Worrell received equity awards in the form of restricted stock units. On July 1, 2026, she was granted 1,777 2026 Elective Restricted Stock Units and 1,623 2026 Annual Restricted Stock Units, each representing the right to receive one share of Class A common stock.
The 2026 Annual RSUs vested on July 1, 2026, with settlement scheduled within 60 days following July 1, 2028. The 2026 Elective RSUs vest in four equal installments at the beginning of each quarter through July 1, 2027, with settlement within 60 days after each vesting date. These are compensation-related grants rather than open-market share purchases or sales.
Shropshire Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Kenneth Shropshire reported equity awards in the form of restricted stock units, not open-market trades. On July 1, 2026, he received 1,700 "2026 Annual Restricted Stock Units" and 200 "2026 Elective Restricted Stock Units," each representing one share of Class A common stock.
The RSUs were granted based on an average share price of $64.68 over the five trading days ended June 30, 2026. The 2026 Annual RSUs vested on July 1, 2026 and are scheduled to settle within 60 days after July 1, 2028. The 2026 Elective RSUs vest in equal quarters through July 1, 2027, with settlement within 60 days after each vesting date, reflecting routine non-employee director compensation.
Moelis & Company reported the results of its 2026 Annual Meeting of Stockholders held on June 25, 2026. Stockholders elected seven directors to the board, with each nominee receiving more votes for than against. Support levels varied by director but all were approved with additional broker non-votes recorded.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with over 80 million votes cast in favor versus approximately 25 million against. In addition, they ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with a large majority of votes cast in favor.
Barker Thorold reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Barker Thorold received a grant of 15.9600 2025 Annual Restricted Stock Units as equity compensation. Each RSU represents the right to receive one share of Class A Common Stock. These RSUs were issued as dividend equivalents on underlying Annual RSUs issued on July 14, 2025 and will vest at the same time as that underlying award.
After this grant, Thorold’s direct holdings reported in this filing total 1665.2500 shares/units of Moelis & Co Class A equity. The transaction reflects a stock-based award rather than an open-market purchase or sale.
Moelis & Co director Louise Mirrer reported awards of additional restricted stock units tied to prior grants rather than any open-market trades. On June 18, 2026, she acquired 16.7600 2025 Annual RSUs and 0.3800 and 12.3900 2024 Annual RSUs, all at a stated price of $0.00 per unit.
Each RSU represents the right to receive one share of Class A Common Stock. The 2024 and 2025 Annual RSUs were issued as dividend equivalents on underlying annual RSU awards and will vest on the same schedule as those underlying grants. These are compensation-related equity accruals, not purchases or sales in the market.
Shropshire Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Kenneth Shropshire reported routine equity compensation changes involving Restricted Stock Units (RSUs). On June 18, 2026, he was awarded 0.52 2025 Elective RSUs, 17.55 2025 Annual RSUs, and 21.03 2024 Annual RSUs, all at a reported price of $0.0000 per unit.
Each RSU represents the right to receive one share of Class A Common Stock. The 2024 and 2025 Annual RSUs and 2025 Elective RSUs were issued as dividend equivalents on underlying RSUs and will vest at the same time as those underlying awards. Following these awards, his reported RSU holdings in the respective series increased to 54.09, 1,831.67, and 2,194.94 units.
Moelis & Co director Laila Worrell reported grants of additional restricted stock units (RSUs) that function as dividend equivalents on existing awards. On 2026-06-18, she acquired 4.6000 2025 Elective RSUs, 16.7600 2025 Annual RSUs, and 20.0800 2024 Annual RSUs at a stated price of $0.0000 per unit. Each RSU represents the right to receive one share of Class A Common Stock. Following these awards, her reported direct holdings in these RSU categories increased to 479.5000, 1748.4600, and 2095.4700 units, respectively. The footnotes clarify that the 2024 and 2025 Annual and Elective RSUs were issued as dividend equivalents and will vest concurrently with the underlying RSUs.